-
公开(公告)号：US20180221473A1
公开(公告)日：2018-08-09
申请号：US15705006
申请日：2017-09-14
申请人： Genentech, Inc.
发明人： Gwendolyn FYFE , Eric HOLMGREN , Robert D. MASS , William NOVOTNY
IPC分类号： A61K39/395 , A61K45/06 , A61K31/282 , A61K31/337 , A61K31/4745 , A61K31/513 , A61K31/519 , C07K16/30 , C07K16/22 , A61K9/00 , A61K31/7068 , A61K31/555 , A61K39/00
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20210015918A1
公开(公告)日：2021-01-21
申请号：US17033141
申请日：2020-09-25
申请人： Genentech, Inc.
发明人： Gwendolyn FYFE , Eric HOLMGREN , Robert D. MASS , William NOVOTNY
IPC分类号： A61K39/395 , A61K45/06 , A61K31/522 , A61K38/50 , A61K31/525 , A61K31/573 , A61K38/09 , A61K38/21 , C07K16/22 , A61K31/282 , A61K31/4545 , A61K31/513 , A61K31/519 , A61K31/337 , A61K31/4745 , A61K31/7068 , A61K9/00 , A61K31/555 , C07K16/30
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20200171148A1
公开(公告)日：2020-06-04
申请号：US16781281
申请日：2020-02-04
申请人： Genentech, Inc.
发明人： Gwendolyn FYFE , Eric HOLMGREN , Robert D. MASS , William NOVOTNY
IPC分类号： A61K39/395 , A61K38/21 , A61K38/09 , A61K31/573 , A61K31/525 , A61K38/50 , A61K31/522 , C07K16/30 , A61K31/555 , A61K9/00 , A61K31/7068 , A61K31/4745 , A61K31/337 , A61K31/519 , A61K31/513 , A61K31/4545 , A61K31/282 , C07K16/22 , A61K45/06
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20160304594A1
公开(公告)日：2016-10-20
申请号：US15080897
申请日：2016-03-25
申请人： Genentech, Inc.
发明人： Gwendolyn FYFE , Eric HOLMGREN , Robert D. MASS , William NOVOTNY
IPC分类号： C07K16/22 , A61K45/06 , A61K31/513 , C07K16/30 , A61K31/4745 , A61K31/555 , A61K9/00 , A61K39/395 , A61K31/519
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20150359881A1
公开(公告)日：2015-12-17
申请号：US14597754
申请日：2015-01-15
申请人： GENENTECH, INC.
发明人： Gwendolyn FYFE , Eric HOLMGREN , Robert D. MASS , William NOVOTNY
IPC分类号： A61K39/395 , A61K31/519 , A61K45/06 , A61K31/282 , A61K31/7068 , A61K31/337 , A61K31/513 , A61K31/4745
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20230218755A1
公开(公告)日：2023-07-13
申请号：US18183467
申请日：2023-03-14
申请人： Genentech, Inc.
发明人： Gwendolyn FYFE , Eric HOLMGREN , Robert D. MASS , William NOVOTNY
IPC分类号： A61K39/395 , C07K16/22 , A61K31/525 , A61K31/519 , C07K16/30 , A61K31/4545 , A61K9/00 , A61K38/50 , A61K31/337 , A61K31/282 , A61K38/09 , A61K31/555 , A61K31/522 , A61K31/573 , A61K38/21 , A61K31/513 , A61K31/7068 , A61K31/4745 , A61K45/06 , A61K39/00
CPC分类号： A61K39/3955 , C07K16/22 , A61K31/525 , A61K31/519 , C07K16/3046 , A61K31/4545 , A61K9/0019 , A61K39/39541 , A61K38/50 , A61K31/337 , A61K31/282 , A61K38/09 , A61K31/555 , A61K31/522 , A61K31/573 , A61K38/212 , A61K31/513 , A61K31/7068 , A61K39/39558 , A61K31/4745 , A61K45/06 , A61K2039/505 , C07K2317/567 , C07K2317/565 , C07K2317/24 , C07K2317/76 , C07K2317/21
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20190307881A1
公开(公告)日：2019-10-10
申请号：US16452144
申请日：2019-06-25
申请人： Genentech, Inc.
发明人： Gwendolyn FYFE , Eric HOLMGREN , Robert D. MASS , William NOVOTNY
IPC分类号： A61K39/395 , A61K31/555 , A61K31/513 , A61K31/282 , A61K45/06 , A61K31/4745 , A61K31/4545 , C07K16/22 , C07K16/30 , A61K9/00 , A61K31/519 , A61K31/7068 , A61K31/337
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
公开(公告)号：US20160310592A1
公开(公告)日：2016-10-27
申请号：US15198769
申请日：2016-06-30
申请人： Genentech, Inc.
发明人： Gwendolyn FYFE , Eric HOLMGREN , William NOVOTNY
IPC分类号： A61K39/395 , A61K31/519 , A61K31/4745 , A61K45/06 , A61K31/513
CPC分类号： A61K39/3955 , A61K9/0019 , A61K31/282 , A61K31/337 , A61K31/4545 , A61K31/4745 , A61K31/513 , A61K31/519 , A61K31/522 , A61K31/525 , A61K31/555 , A61K31/573 , A61K31/7068 , A61K38/09 , A61K38/212 , A61K38/50 , A61K39/39541 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/22 , C07K16/3046 , C07K2317/21 , C07K2317/24 , C07K2317/565 , C07K2317/567 , C07K2317/76 , A61K2300/00
摘要： This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.019 秒)
